As of 2024-12-15, the Fair Value of Summit Therapeutics Inc (SMMT) is -0.63 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.83 USD, the upside of Summit Therapeutics Inc is -103.53%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -29.13 | -52.70 | -88.60 | -78.78 | -614.93 | -172.83 |
| YoY growth | -394.24% | -80.91% | -68.12% | 11.08% | -680.56% | -242.55% |
| Market Cap (mil) | 13,148.73 |
| P/E | |
| Forward P/E |
| EPS | -0.13 |
| Avg earnings growth rate | -242.55% |
| TTM earnings | -92.82 |